Parkinson disease

You have access
Dopaminergic Nigrostriatal Connectivity in Early Parkinson Disease: In Vivo Neuroimaging Study of ¹¹C-DTBZ PET Combined with Correlational Tractography
Carlos A. Sanchez-Catasus, Nicolaas I. Bohnen, Fang-Cheng Yeh, Nicholas D’Cruz, Prabesh Kanel and Martijn L.T.M. Müller

Journal of Nuclear Medicine April 1, 2021, 62 (4) 545-552; DOI: https://doi.org/10.2967/jnumed.120.248500
You have access
Cerebral Metabolic Changes Related to Freezing of Gait in Parkinson Disease
Trina Mitchell, Alexandra Potvin-Desrochers, Anne-Louise Lafontaine, Oury Monchi, Alexander Thiel and Caroline Paquette

Journal of Nuclear Medicine May 1, 2019, 60 (5) 671-676; DOI: https://doi.org/10.2967/jnumed.118.218248
You have access
Noradrenergic Deficits in Parkinson Disease Imaged with ¹¹C-MeNER
Adjmal Nahimi, Michael Sommerauer, Martin B. Kinnerup, Karen Østergaard, Michael Wintherdahl, Jan Jacobsen, Anna Schacht, Birger Johnsen, Malene F. Damholdt, Per Borghammer and Albert Gjedde

Journal of Nuclear Medicine April 1, 2018, 59 (4) 659-664; DOI: https://doi.org/10.2967/jnumed.117.190975
You have access
¹⁸F-FDG PET in Parkinsonism: Differential Diagnosis and Evaluation of Cognitive Impairment
Philipp T. Meyer, Lars Frings, Gerta Rücker and Sabine Hellwig

Journal of Nuclear Medicine December 1, 2017, 58 (12) 1888-1898; DOI: https://doi.org/10.2967/jnumed.116.186403
You have access
Management Impact of Imaging Brain Vesicular Monoamine Transporter Type 2 in Clinically Uncertain Parkinsonian Syndrome with ¹⁸F-AV133 and PET
Paschal K. Alexander, Yenni Lie, Gareth Jones, Chomalaven Sivaratnam, Svetlana Bozinvski, Rachel S. Mulligan, Kenneth Young, Victor L. Villemagne and Christopher C. Rowe

Journal of Nuclear Medicine November 1, 2017, 58 (11) 1815-1820; DOI: https://doi.org/10.2967/jnumed.116.189019
You have access
2-Year Natural Decline of Cardiac Sympathetic Innervation in Idiopathic Parkinson Disease Studied with ¹¹C-Hydroxyephedrine PET
Ka Kit Wong, David M. Raffel, Nicolaas I. Bohnen, Gulcin Altinok, Sid Gilman and Kirk A. Frey

Journal of Nuclear Medicine February 1, 2017, 58 (2) 326-331; DOI: https://doi.org/10.2967/jnumed.116.176891
You have access
Optimal Acquisition Time Window and Simplified Quantification of Dopamine Transporter Availability Using ¹⁸F-FE-PE2I in Healthy Controls and Parkinson Disease Patients
Ida Sonni, Patrik Fazio, Martin Schain, Christer Halldin, Per Svenningsson, Lars Farde and Andrea Varrone

Journal of Nuclear Medicine October 1, 2016, 57 (10) 1529-1534; DOI: https://doi.org/10.2967/jnumed.115.171231
You have access
Automated Differential Diagnosis of Early Parkinsonism Using Metabolic Brain Networks: A Validation Study
Madhavi Tripathi, Chris C. Tang, Andrew Feigin, Ivana De Lucia, Amir Nazem, Vijay Dhawan and David Eidelberg

Journal of Nuclear Medicine January 1, 2016, 57 (1) 60-66; DOI: https://doi.org/10.2967/jnumed.115.161992
You have access
Quantitative Analysis of ¹⁸F-(E)-N-(3-Iodoprop-2-Enyl)-2β-Carbofluoroethoxy-3β-(4′-Methyl-Phenyl) Nortropane Binding to the Dopamine Transporter in Parkinson Disease
Patrik Fazio, Per Svenningsson, Anton Forsberg, Erik G. Jönsson, Nahid Amini, Ryuji Nakao, Sangram Nag, Christer Halldin, Lars Farde and Andrea Varrone

Journal of Nuclear Medicine May 1, 2015, 56 (5) 714-720; DOI: https://doi.org/10.2967/jnumed.114.152421

Main menu

User menu

Search

Parkinson disease